Effects of intracerebroventricularly-injected morphine on anxiety, memory retrieval and locomotor activity in rats: Involvement of vasopressinergic system and nitric oxide pathway

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 4, 2006, Pages 859-867

  Kahveci, Nevzat ^a   Gulec, Guldal ^a   Ozluk, Kasim ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Anxiety; Locomotor activity; Memory; Morphine; Nitric oxide; Vasopressin

Indexed keywords

ARGIPRESSIN RECEPTOR; MORPHINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MAZE TEST; MORRIS WATER MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECALL; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY; MORPHINE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 33846462452     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.11.023     Document Type: Article

References (58)

1. Anseloni V.C., Coimbra N.C., Morato S., and Brandao M.L. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test. Exp Brain Res 129 (1999) 260-268
2. Appenrodt E., Schnabel R., and Schwarzberg H. Vasopressin administration modulates anxiety-related behavior in rats. Physiol Behav 64 (1998) 543-547
3. Barcia J.A., Rubio P., Alos M., Serralta A., and Belda V. Anticonvulsant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amygdala-kindling model of epilepsy in the rat. Epilepsy Res 33 (1999) 159-167
4. Bauco P., Wang Y., and Wise R.A. Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res 617 (1993) 303-308
5. Belknap J.K., Riggan J., Cross S., Young E.R., Gallaher E.J., and Crabbe J.C. Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 59 (1998) 353-360
6. Bielsky I.F., and Young L.J. Oxytocin, vasopressin, and social recognition in mammals. Peptides 25 (2004) 1565-1574
7. Bielsky I.F., Hu S.B., Ren X., Terwilliger E.F., and Young L.J. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 47 (2005) 503-513
8. Bruins Slot L.A., and Colpaert F.C. Opiate states of memory: receptor mechanisms. J Neurosci 19 (1999) 10520-10529
9. Cano-Martinez A., Villalobos-Molina R., and Rocha L. Effects of chronic morphine and N(6)-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus. Epilepsy Res 44 (2001) 89-96
10. Clement Y., and Chapouthier G. Biological bases of anxiety. Neurosci Biobehav Rev 22 (1998) 623-633
11. Cunningham S.T., and Kelley A.E. Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain Res Bull 29 (1992) 675-680
12. Cunningham S.T., and Kelley A.E. Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward. Brain Res 588 (1992) 104-114
13. Diamant M., and de Wied D. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats. Am J Physiol 264 (1993) R51-R61
14. Faria M.S., Muscara M.N., Moreno J.H., Teixeira S.A., Dias H.B., De Oliveira B., et al. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur J Pharmacol 323 (1997) 37-43
15. Firemark H.M., and Weitzman R.E. Effects of beta-endorphin, morphine and naloxone on arginine vasopressin secretion and the electroencephalogram. Neuroscience 4 (1979) 1895-1902
16. Gulati K., and Ray A. Effects of intrahypothalamic morphine and its interactions with oxytocin and vasopressin during food intake in rats. Brain Res 690 (1995) 99-103
17. Hammock E.A., Lim M.M., Nair H.P., and Young L.J. Association of vasopressin 1a receptor levels with a regulatory microsatellite and behavior. Genes Brain Behav 4 (2005) 289-301
18. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedebergs Arch Pharmacol 327 (1984) 1-5
19. Harbaugh R.E., Saunders R.L., and Reeder R.F. Use of implantable pumps for central nervous system drug infusions to treat neurological disease. Neurosurgery 23 (1988) 693-698
20. Izquierdo I. Effect of naloxone and morphine on various forms of memory in the rat: possible role of engogenous opiate mechanisms in memory consolidation. Psychopharmacology (Berl) 66 (1979) 199-203
21. Kalivas P.W., Widerlov E., Stanley D., Breese G., and Prange Jr. A.J. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227 (1983) 229-337
22. Khavandgar S., Homayoun H., Torkaman-Boutorabi A., and Zarrindast M.R. The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiol Learn Mem 78 (2002) 390-405
23. Khavandgar S., Homayoun H., and Zarrindast M.R. The effect of l-NAME and l-arginine on impairment of memory formation and state-dependent learning induced by morphine in mice. Psychopharmacology (Berl) 167 (2003) 291-296
24. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 66 (2002) 285-306
25. Kivastik T., Rutkauskaite J., and Zharkovsky A. Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol Biochem Behav 53 (1996) 1013-1015
26. Koks S., Soosaar A., Voikar V., Bourin M., and Vasar E. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides 33 (1999) 63-69
27. Le Merrer J., Cagniard B., and Cazala P. Modulation of anxiety by mu-opioid receptors of the lateral septal region in mice. Pharmacol Biochem Behav 83 3 (2006) 465-479
28. Li Z., Wu C.F., Pei G., Guo Y.Y., and Li X. Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacol Biochem Behav 66 (2000) 595-601
29. Li Z., Wu C.F., Pei G., and Xu N.J. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system. Pharmacol Biochem Behav 68 (2001) 507-513
30. Liebsch G., Wotjak C.T., Landgraf R., and Engelmann M. Septal vasopressin modulates anxiety-related behaviour in rats. Neurosci Lett 217 (1996) 101-104
31. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
32. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
33. McNamara R.K., and Skelton R.W. Pharmacological dissociation between the spatial learning deficits produced by morphine and diazepam. Psychopharmacology (Berl) 108 (1992) 147-152
34. Meilandt W.J., Barea-Rodriguez E., Harvey S.A., and Martinez Jr. J.L. Role of hippocampal CA3 mu-opioid receptors in spatial learning and memory. J Neurosci 24 (2004) 2953-2962
35. Milanes M.V., Laorden M.L., Chapleur-Chateau M., and Burlet A. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response. Naunyn-Schmiedebergs Arch Pharmacol 356 (1997) 603-610
36. Motta V., and Brandao M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 44 (1993) 119-125
37. Murphy N.P., Lam H.A., and Maidment N.T. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem 79 (2001) 626-635
38. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16 (1993) 1-18
39. Patti C.L., Frussa-Filho R., Silva R.H., Carvalho R.C., Kameda S.R., Takatsu-Coleman A.L., et al. Behavioral characterization of morphine effects on motor activity in mice. Pharmacol Biochem Behav 81 (2005) 923-927
40. Patti C.L., Kameda S.R., Carvalho R.C., Takatsu-Coleman A.L., Lopez G.B., Niigaki S.T., et al. Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning. Psychopharmacology (Berl) 184 (2006) 1-12
41. Peart J.N., Gross E.R., and Gross G.J. Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol 42 (2005) 211-218
42. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
43. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
44. Raehal K.M., and Bohn L.M. Mu opioid receptor regulation and opiate responsiveness. AAPS J 7 (2005) E587-E591
45. Rezayof A., Amini R., Rassouli Y., and Zarrindast M.R. Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents. Physiol Behav 88 1-2 (2006) 124-131
46. Rodriguez-Arias M., Broseta I., Aguilar M.A., and Minarro J. Lack of specific effects of selective D(1) and D(2) dopamine antagonists vs. risperidone on morphine-induced hyperactivity. Pharmacol Biochem Behav 66 (2000) 189-197
47. Sahraei H., Poorheidari G., Foadaddini M., Sabetkasaei M., Ghoshooni H., Khalili M., et al. Effects of nitric oxide on morphine self-administration in rat. Pharmacol Biochem Behav 77 (2004) 111-116
48. Sala M., Braida D., Leone M.P., Calcaterra P., Frattola D., and Gori E. Chronic morphine affects working memory during treatment and withdrawal in rats: possible residual long-term impairment. Behav Pharmacol 5 (1994) 570-580
49. Shin I.C., Kim H.C., Swanson J., Hong J.T., and Oh K.W. Anxiolytic effects of acute morphine can be modulated by nitric oxide systems. Pharmacology 68 (2003) 183-189
50. Vaccarino F.J., Amalric M., Swerdlow N.R., and Koob G.F. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav 24 (1986) 61-65
51. Weigl K., Mundinger F., and Chrubasik J. Continuous intraventricular morphine- or peptide-infusion for intractable cancer pain. Acta Neurochir Suppl (Wien) 39 (1987) 163-165
52. Westbrook R.F., Good A.J., and Kiernan M.J. Microinjection of morphine into the nucleus accumbens impairs contextual learning in rats. Behav Neurosci 111 (1997) 996-1013
53. Wilkens E.P., and Yates B.J. Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets. Anesth Analg 101 (2005) 1029-1033
54. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 94 (1987) 469-492
55. Yamashiro O., Takahashi M., and Kaneto H. Role of vasopressin in the blockade of the development of morphine tolerance by footshock and psychological stress. Arch Int Pharmacodyn Ther 307 (1990) 60-70
56. Zarrindast M.R., Karami M., Sepehri H., and Sahraei H. Influence of nitric oxide on morphine-induced conditioned place preference in the rat central amygdala. Eur J Pharmacol 453 (2002) 81-89
57. Zarrindast M.R., Gholami A., Sahraei H., and Haeri-Rohani A. Role of nitric oxide in the acquisition and expression of apomorphine- or morphine-induced locomotor sensitization. Eur J Pharmacol 482 (2003) 205-213
58. Zarrindast M.R., Rostami P., Zarei M., and Roohbakhsh A. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic Clin Pharmacol Toxicol 97 (2005) 276-281